Everyone who has ever eaten a cannabis edible knows the experience is fundamentally different from smoking. The onset is slower. The peak is more intense. The duration is longer. And the subjective quality of the high — that deep, full-body, sometimes overwhelming experience — feels like a different drug entirely.
It is, in a pharmacological sense, a different drug. When you eat cannabis, your liver converts delta-9-THC into 11-hydroxy-THC (11-OH-THC), a metabolite that crosses the blood-brain barrier more efficiently and binds to CB1 receptors with significantly greater potency. Of course, the THC in your edible had to be created first through decarboxylation — the chemical reaction that converts inactive THCa into psychoactive THC. This single biochemical transformation explains virtually everything that makes edibles hit different.
But the full story involves multiple organ systems, competing metabolic pathways, and individual genetic variation that makes edible experiences wildly unpredictable from person to person. Understanding the neuroscience doesn’t just satisfy curiosity — it helps you dose safely and set appropriate expectations.
The Two Pathways: Lungs vs. Liver
When you inhale cannabis smoke or vapor, THC crosses the thin alveolar membranes in your lungs and enters the pulmonary blood supply directly. From there, it reaches arterial blood within seconds and is delivered to the brain in a single circulatory pass. Peak blood THC concentrations occur within 3 to 10 minutes of inhalation. The effect is fast, predictable, and self-titrating — you feel each hit within minutes and can stop when you’ve reached your desired level.
When you eat cannabis, the pathway is radically different. THC must first survive the acidic environment of the stomach, then be absorbed through the walls of the small intestine into the portal blood supply. This portal blood flows directly to the liver before entering general circulation — a routing known as first-pass metabolism.
In the liver, cytochrome P450 enzymes (primarily CYP2C9 and CYP3A4) convert delta-9-THC into 11-hydroxy-THC. This is not a minor modification. The hydroxylation at the 11-position creates a metabolite that is more water-soluble, crosses the blood-brain barrier more readily, and produces more intense psychoactive effects per milligram than the parent compound.
Research published in the Journal of Clinical Pharmacology estimates that 11-OH-THC is two to four times more potent at CB1 receptors than delta-9-THC. This potency amplification means that even a modest oral dose can produce effects equivalent to a much larger inhaled dose — but with a delay that makes real-time dose adjustment impossible.
The Timeline: Why the Wait, and Why the Wave
The pharmacokinetic profiles of inhaled and oral THC could not be more different. Understanding the timeline is critical for safe dosing.
Inhaled THC:
- Onset: 1–5 minutes
- Peak blood concentration: 3–10 minutes
- Duration of primary effects: 1–3 hours
- Full clearance from blood: 3–6 hours
Oral THC (edibles):
- Onset: 30–120 minutes (sometimes longer)
- Peak blood concentration: 60–180 minutes
- Duration of primary effects: 4–8 hours
- Full clearance from blood: 8–24 hours
The wide variability in oral onset time is one of the most dangerous features of edibles for inexperienced users. Factors that influence absorption speed include stomach contents (fat accelerates THC absorption), metabolic rate, gut motility, and the formulation of the edible itself. A gummy on an empty stomach might hit in 30 minutes. A dense brownie after a heavy meal might take 2 hours.
This variability is the primary driver of emergency room visits related to cannabis edibles. The classic pattern: a user eats a dose, feels nothing after 45 minutes, takes a second dose, and then both doses hit simultaneously 30 minutes later. The result is a THC blood concentration far beyond what they intended.
The First-Pass Effect: Your Liver as an Amplifier
The hepatic first-pass effect is the pharmacological phenomenon that defines the edible experience. When THC passes through the liver before reaching the brain, the conversion to 11-OH-THC is extensive — studies suggest that 50% to 90% of ingested THC is metabolized on the first pass, depending on individual liver enzyme activity.
This means that when you eat 10mg of THC, you are not simply getting 10mg of THC delivered slowly to your brain. You are getting a complex mixture of delta-9-THC, 11-OH-THC, and further metabolites (including 11-nor-9-carboxy-THC, or THC-COOH, which is inactive but is the primary metabolite detected in drug tests) in ratios that vary by individual.
The ratio of 11-OH-THC to delta-9-THC in your blood after eating an edible is roughly 1:1 to 2:1. After smoking, this ratio is approximately 1:10 — you get far less of the potent metabolite. This ratio difference is the single most important factor in explaining why edibles feel stronger, more psychedelic, and more full-body than inhaled cannabis.
Why Some People Don’t Feel Edibles at All
Approximately 10-15% of cannabis users report that edibles produce minimal or no effect regardless of dose. The explanation lies in genetic variation in cytochrome P450 enzymes.
CYP2C9, the primary enzyme responsible for THC metabolism, has well-characterized genetic polymorphisms. The CYP2C9*3 variant, carried by approximately 12% of Caucasian populations and 3% of African American populations, results in significantly reduced enzyme activity. Individuals who are homozygous for this variant metabolize THC much more slowly — which means less conversion to 11-OH-THC, lower peak concentrations, and a subjectively weaker edible experience.
Conversely, ultra-rapid metabolizers (who carry CYP2C9*1/*1 genotype with additional enzyme induction from regular use) convert THC to 11-OH-THC very efficiently. These individuals tend to have intense edible experiences even at moderate doses.
CYP3A4 variation adds another layer of complexity. This enzyme participates in both the activation (THC → 11-OH-THC) and the deactivation (11-OH-THC → THC-COOH) pathways. The balance between these two functions determines how much active metabolite reaches the brain and how long it stays there.
Gut health also plays a role. Conditions that affect intestinal absorption — Crohn’s disease, celiac disease, bariatric surgery, or even recent antibiotic use that has disrupted the gut microbiome — can significantly alter how much THC is absorbed from an edible. Users with gastrointestinal conditions often report inconsistent edible experiences.
The Blood-Brain Barrier: Why 11-OH-THC Hits Harder
Delta-9-THC is highly lipophilic — it dissolves readily in fat but has moderate ability to cross the blood-brain barrier. 11-OH-THC, despite being slightly more water-soluble due to its hydroxyl group, actually crosses the blood-brain barrier more efficiently. The mechanism is not fully understood, but it may involve active transport by specific carrier proteins that recognize the hydroxylated structure.
Once across the blood-brain barrier, 11-OH-THC binds to CB1 receptors in the same brain regions as delta-9-THC: the prefrontal cortex (executive function, decision-making), the hippocampus (memory formation), the amygdala (emotional processing), the basal ganglia (movement), and the cerebellum (coordination).
However, the binding kinetics differ. Some researchers hypothesize that 11-OH-THC has a slower dissociation rate from CB1 receptors — it binds and stays bound longer than delta-9-THC. This could explain why the edible high feels more sustained and “deep” compared to the relatively quick peak-and-fade pattern of smoking.
The higher peak concentrations of 11-OH-THC also mean more extensive CB1 receptor occupancy in brain regions that are not strongly activated by typical inhaled doses. At high edible doses, CB1 activation in the amygdala can trigger intense anxiety or paranoia, while activation in the temporal lobe can produce perceptual distortions that users describe as “psychedelic” — visual tracers, time dilation, and synesthesia-like effects.
The Role of Fat: Lipid-Based Absorption
THC is fat-soluble, and its intestinal absorption is dramatically enhanced by co-ingestion with lipids. A study published in the European Journal of Clinical Pharmacology found that taking oral THC with a high-fat meal increased peak blood concentrations by approximately 2.5-fold compared to a fasting state.
This has practical implications for dosing:
The fat effect means:
- Edibles made with butter, coconut oil, or other fats are absorbed more completely than edibles in non-fat formulations (like some gummies)
- Eating a fatty meal before or with an edible increases both the speed and intensity of the effect
- Taking an edible on an empty stomach produces a slower, less complete absorption — which paradoxically may result in a weaker but more unpredictable experience
The cannabis industry has begun exploiting this pharmacology with nano-emulsion technology, which breaks THC into microscopic lipid droplets that are absorbed more rapidly and completely through the intestinal wall. Nano-emulsified edibles can produce onset times of 15-30 minutes — closer to inhaled cannabis — and more consistent dosing.
Second-Pass Effects and the Long Tail
The edible experience has a “long tail” that smoking does not. After 11-OH-THC is eventually metabolized by the liver into THC-COOH (the inactive carboxylated metabolite), it enters the enterohepatic circulation — a recycling loop where metabolites are excreted in bile, reabsorbed in the intestine, and returned to the liver for further processing.
This recycling can produce secondary peaks in THC blood concentration 4–6 hours after initial ingestion. Users sometimes describe this as a “second wave” of effects — just when they think the edible is wearing off, they experience a mild resurgence. This is not psychosomatic. It is a real pharmacokinetic phenomenon driven by enterohepatic recirculation.
The long elimination half-life of oral THC metabolites also explains why edible hangovers are more common and more severe than smoking hangovers. Residual 11-OH-THC and its metabolites can persist in the bloodstream for 12–24 hours, producing low-level effects (brain fog, fatigue, mild perceptual changes) well into the next day.
Sublingual and Buccal: The Middle Path
Not all oral cannabis products follow the full gastrointestinal pathway. Sublingual tinctures, oral sprays, and dissolvable strips are designed to be absorbed through the mucous membranes of the mouth, bypassing the first-pass liver metabolism entirely or partially.
The sublingual pathway delivers THC directly into the sublingual vein, which drains into the internal jugular vein and reaches the heart without passing through the liver first. The pharmacokinetic profile of sublingual THC is intermediate between smoking and eating:
- Onset: 15–45 minutes
- Peak: 30–90 minutes
- Duration: 2–5 hours
Because sublingual absorption partially bypasses the liver, the ratio of 11-OH-THC to delta-9-THC is lower than with edibles but higher than with smoking. The subjective experience reflects this — more intense than smoking, less intense than a full edible, with faster onset and shorter duration.
However, true sublingual absorption requires holding the product under the tongue for 60–90 seconds without swallowing. Most users swallow some portion of the product, creating a mixed absorption profile that varies from use to use.
Practical Implications: How to Dose Smarter
Understanding the pharmacology leads to practical dosing strategies:
Start low: 2.5mg is a reasonable starting dose for edible-naive users — see our THC dosing guide for detailed recommendations by experience level. This is half the standard “unit dose” of 5mg used in most legal markets. The amplification from 11-OH-THC means 2.5mg oral can produce effects comparable to a moderate inhaled dose.
Wait long: The “golden rule” of edibles is to wait at least 2 hours before redosing. Given the variability in onset times, 2 hours is the minimum — 3 hours is safer for first-time users.
Consider fat content: If you want a more predictable experience, take your edible with a small fatty snack. If you want to reduce intensity, take it on an emptier stomach (but expect more variability in onset time).
Know your genetics: If edibles consistently feel either overwhelming or underwhelming at standard doses, genetic variation in CYP2C9 enzymes may be the explanation. Pharmacogenomic testing can identify your metabolizer status.
Respect the long tail: Plan for 6-8 hours of effects, not 2-3. Edibles are not a “quick session” product. They are a commitment.
The neuroscience of edibles is a story about how a single enzymatic reaction — the hydroxylation of THC at the 11-position — transforms one drug into another. Understanding this transformation is the difference between a carefully dosed, enjoyable experience and the kind of overwhelming misadventure that has defined edible culture since the first batch of pot brownies came out of the oven. Ready to make your own? Start with our guides to making cannabutter and making edibles at home.